Lucentis is an anti-VegF drug ranibizumab used to treat Wet AMD
and macular edema associated with retinal vein occlusion (RVO).
Ozurdex is a dexamethasone implant used to treat macular edema
associated with retinal vein occlusion (RVO) as well as
non-infectous posterior segment uveitis. For RVO, the two drugs
work differently but Ozurdex is seen to last longer than Lucentis
and therefore less frequent injections. Ask your doctor for more
details and for which one is right for you.